DESFERAL Sterile, lyophilised powder Ref.[2723] Active ingredients: Deferoxamine

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2020  Publisher: Novartis Pharmaceuticals UK Limited, 2nd Floor, The WestWorks Building, White City Place, 195 Wood Lane, London, W12 7FQ, United Kingdom

Product name and form

Desferal Vials, 500mg.

Pharmaceutical Form

A sterile, lyophilised powder available in vials containing 500mg of desferrioxamine mesilate.

Qualitative and quantitative composition

Each vial contains desferrioxamine mesilate 500mg.

Active Ingredient Description
Deferoxamine

Deferoxamine is a chelating agent for trivalent iron and aluminium ions. The resulting chelates are stable and non-toxic.

List of Excipients

None present.

Pack sizes and marketing

Each vial contains a white to practically white lyophilisate supplied in a clear glass vial in a pack size of 10 (500 mg).

Marketing authorization holder

Novartis Pharmaceuticals UK Limited, 2nd Floor, The WestWorks Building, White City Place, 195 Wood Lane, London, W12 7FQ, United Kingdom

Marketing authorization dates and numbers

PL00101/0523

31 October 1997 / 12 December 2000

Drugs

Drug Countries
DESFERAL Austria, Brazil, Canada, Cyprus, Estonia, Finland, France, Hong Kong, Ireland, Israel, Italy, Japan, Lithuania, Malta, Netherlands, Poland, Romania, Tunisia, Turkey, United Kingdom, United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.